Table 2 Effects of the treatment in the groups
|  | Phlebotomy N = 27 | P-value* | OCs N = 30 | P-value* | P-value** | ||
|---|---|---|---|---|---|---|---|
3 months post-treatment | Mean difference | 3 months post-treatment | Mean difference | ||||
BMI | 27 (4.7) | −0.01 | 0.229 | 25.1 (5.3) | −0.03 | 0.784 | 0.355 |
WHR | 0.8 (0.04) | −0.01 | 0.346 | 0.7 (0.05) | −0.01 | 0.621 | 0.412 |
Hirsutism score | 13.3 (7.4) | −3.7 (6.1) | 0.028 | 9.8 (7.6) | −2.1 (2.8) | 0.001 | 0.235 |
SBP, (mm Hg) | 101.1 (6.5) | −1.1 (10.3) | 0.647 | 102 (8.4) | 1.5 (20.1) | 0.690 | 0.610 |
DBP, (mm Hg) | 65.8 (7.7) | −1.7 (10.8) | 0.514 | 65.8 (5.3) | −0.5 (10) | 0.780 | 0.701 |
HOMA_IR | 2.7 (1.2–4.3) | −0.73 (2) | 0.047 | 2.8 (1.8–3.9) | −0.45 (5.6) | 0.032 | 0.516 |
Insulin, (μU/mL) | 8.1 (6.5–15.7) | −0.5 (10.1) | 0.025 | 9.8 (7.8–16.1) | −4.6 (23.8) | 0.015 | 0.512 |
FAI | 4.1 (1.8–8) | −1.1 (3.4) | 0.042 | 3.1 (0.3–6.8) | −1.2 (2.9) | 0.001 | 0.061 |
Total Testosterone, (ng/mL) | 0.42 (0.34) | −0.07 (0.1) | 0.047 | 0.33 (0.1) | −0.06 (0.1) | 0.045 | 0.378 |
Androstenedione, (ng/mL) | 3.3 (1.7) | −1.3 (1.3) | 0.026 | 2.9 (1.6) | −1.1 (1.8) | 0.001 | 0.070 |
SHBG, (nmol/L) | 91.1 (72.4) | 55.6 (63) | 0.013 | 163.7 (101.5) | 107.06 (115.4) | 0.001 | 0.009 |
Cholesterol, (mg/dL) | 179.8 (67.1) | 1.2 (69.4) | 0.940 | 183.2 (41) | 3.4 (32.5) | 0.076 | 0.102 |
Triglycerides, (mg/dL) | 123.8 (93.4) | 8.3 (83.9) | 0.687 | 152 (89.9) | 37.7 (65.1) | 0.004 | 0.019 |
HDL, (mg/dL) | 43 (15.6) | −2.5 (13.9) | 0.467 | 51.9 (15) | 4.4 (11.2) | 0.053 | 0.072 |
LDL, (mg/dL) | 93.4 (27) | −2.1 (22.9) | 0.709 | 105.9 (33.4) | 8.8 (32.2) | 0.150 | 0.187 |
AMH, (ng/mL) | 8 (5.4) | −0.1 (3.6) | 0.909 | 6.7 (3.8) | −1.9 (5) | 0.043 | 0.191 |
PSA, (ng/mL) | 0.002 (0.002–0.008) | 0.003 (0.01) | 0.427 | 0.002 (0.002–0.01) | −0.005 (0.01) | 0.204 | 0.058 |